NCT02145260View on ClinicalTrials.gov

Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

May 3, 2021

Conditions
Intra-dialytic Hypotension
Interventions
DRUG

Lower dialysate sodium (138 mmol/L; using Renasol hemodialysis concentrate)

A lower dialysate sodium will bes used in the active comparator arm (138 mmol/L)

DRUG

Higher dialysate sodium (142 mmol/L; using Renasol hemodialysis concentrate)

A higher dialysate sodium will be used in the experimental arm (142 mmol/L)

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT02145260 - Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients | Biotech Hunter | Biotech Hunter